Media Relations
For media inquiries please contact:
ROUTINE & CUSTOM TESTING
Specialty Capabilities
Let's Get Started
Formulation Services
Analytical Services
Manufacturing
Support Services
Company Overview
News & Media
Events
Join Our Team
Our team brings a founder's mentality and client-centered focus united by a common cause, entrepreneurial spirit, and a passion for customer service. Our unique combination of industry experience, technical acumen, and operational wisdom sets the stage for client success and benefits to patients around the globe. We believe these characteristics should influence everything we do in business and life. We love the work that we do, and our clients should reap the benefits.
Pat has been CEO of six high growth organizations over the course of a distinguished 40 year career in the pharmaceutical industry. Prior to Alcami, he was co-founder and CEO of TriPharm Services, a parenteral manufacturing business acquired by Alcami. From 2015 to 2019, Mr. Walsh was the Chief Executive Officer of Avista Pharma Solutions, a private equity-backed global provider of contract manufacturing, development, and analytical testing services acquired by Cambrex. Pat was named CEO of AAIPharma Services Corporation in 2010 and led the company through an impressive growth trajectory, culminating in the sale of the company in 2014. Prior executive roles also include CEO of Kadmus Pharma (acquired by Organon) and President and COO of Gensia-Sicor (acquired by Teva).
In addition to his duties at Alcami, Pat serves as Chairman of the Board of specialty pharma company ANI Pharmaceuticals (NASDAQ: ANIP) and an independent director of private equity backed Institute Chemica Emiliano (I.C.E.) based in Milan Italy. Pat also serves as an Operating Partner at healthcare private equity firm Ampersand Capital. Prior board of director roles include serving as Chairman of Brammer Bio, an independent director at Landec Corp (NASDAQ: LNDC), prIvate equity backed MedPharm Ltd, independent director at Avid BioServices (NASDAQ: CDMO) and numerous other pharma and biotechnology companies over the course of his career.
Ken brings over 25 years of experience in the pharmaceutical industry with considerable experience in finance, mergers, acquisitions, and information system implementations. Ken joined AAIPharma (now Alcami) in 1997 and has served in numerous financial leadership roles throughout his long-standing tenure with the company. Before rejoining Alcami, he was the Vice President and Controller of TriPharm Services, a parenteral contract manufacturing organization acquired by Alcami. Ken has a BS in Accountancy from the University of North Carolina at Wilmington.
Mr. Compton brings over twenty-five years of industry experience with an extensive background in leading commercial operations. Before joining Alcami, Mr. Compton was the Chief Commercial Officer at Avid Bioservices, Inc. (NASDAQ: CDMO), a contract large molecule bulk drug substance development and manufacturer. From 2015 to 2019, Mr. Compton was the Vice President of Sales and Marketing at Avista Pharma, a private equity-backed global provider of contract manufacturing, development, and analytical testing services acquired by Cambrex. Mr. Compton also served in numerous executive leadership roles at AAIPharma Services Corporation, a predecessor company to Alcami, from 2010 to 2014. During the first 10-years of his career, he supported small innovator biotech/pharma start-up companies, advancing drugs from discovery to the clinic. Prior to embarking on a career in commercial operations, his last scientific role was Director of Analytical Development at Kadmus Pharmaceuticals.
Timothy holds a B.S. in Microbiology from Washington State University and is an active duty veteran of the U.S. Army.
Bob joined Alcami in May of 2014 as the Senior Director of Engineering and Facilities and is now the Vice President of Global Engineering. Before joining Alcami, he was the Director of Engineering and Site Services at Catalent Pharma Solutions. Bob has nearly 30 years of industry experience and has held various leadership roles at Pfizer and GE Healthcare. Bob holds a Bachelor of Science degree in Chemical Engineering from North Carolina State University and a Master Certificate in Project Management from the Wisconsin School of Business.
Louise brings over 25 years of industry experience with a successful track record of driving results in drug development and manufacturing operations. Before joining Alcami, she was Vice President of Global Program Management and KBI Biopharma where she led a global team supporting the client interface for biologics drug substance development programs. Prior to that, Louise was the VP, CMC and Program Management at Locus Biosciences, where she led their strategic initiative to in-source GMP manufacturing supporting Pre-Clinical and Phase I clinical trials and established CMC Department focused on developing drug substance and drug product processes for revolutionary bacteriophage technology. In over 14 years with Patheon, Louise held various roles of increasing responsibility in Pharmaceutical Development Services and Project Management. Louise has a Bachelor of Science in Microbiology from the University of Waterloo and a Project Management Professional (PMP) certification from the Project Management Institute.
Katie brings over 25 years of experience in leading laboratory teams. Before returning to Alcami in June 2020, Katie worked for two years at Avista Pharma Solutions/Cambrex where she led the Analytical Development Service team to over 46% year over year growth. She started her career with AAIPharma (now Alcami) in Wilmington as an Assistant Scientist and has progressed through every level of the career ladder. While at AAIPharma, some of her many accomplishments included, implementing 5S principles and streamlining processes, introducing and maintaining Key Performance Indicators (KPI) and metrics, and implementing training and mentoring solutions within the lab teams. Katie holds a Bachelors's and Masters's of Chemistry from the University of North Carolina in Wilmington.
Elliott is an expert in analytical operations with over 18 years of industry experience and a successful track record of leading laboratory operations. Before joining Alcami, he was Vice President and Site Director at Cambrex where he was responsible for leading their Durham, NC site which offers analytical services from R&D through commercial as well as early-phase drug substance development and manufacturing. Prior to this, he was the Executive Director of Analytical Services at Avista Pharma. Elliott received his BS in Biomedical Chemistry from Oral Roberts University and Ph.D. in Chemistry from Northern Illinois University.
Jamie brings more than 25 years of experience in the pharmaceutical industry, including leadership roles in engineering, manufacturing, and supply chain operations. Prior to joining Alcami, Jamie was Chief Manufacturing Officer at Istari Oncology. He has served multiple manufacturing and operations leadership roles throughout his career including executive roles at Xellia Pharmaceuticals, Pfizer, and Hospira.
Jacque joined Alcami in January of 2020 as the Vice President of Quality Operations. Before joining Alcami, she was the Vice President of Quality at TriPharm Services and was responsible for all Quality and Compliance aspects of the company’s parenteral manufacturing operation and related testing. Before this, she used her depth of industry experience as a consultant for private equity firms. Prior to this, she oversaw the Quality and Compliance of externally manufactured Commercial sterile products for Gilead Sciences, which encompassed aseptic processing, blow-fill-seal, and medical device operations, which totaled sixteen sites globally. Before Gilead, she was the Site Head of quality for the AAIPharma aseptic manufacturing facility located in Charleston, SC. Jacque holds a Bachelor of Science degree in Biology from the University of South Carolina.
Before joining Alcami, Chad was the Director, Operations at LSNE Contract Manufacturing, responsible for aseptic and non-aseptic pharmaceuticals and medical devices manufacturing across two sites. Previously, he held roles as the Filling and Lyophilization Manager at Xellia Pharmaceuticals and Biologic Operations Manager at Pfizer. Chad began his career in the United States Air Force as a Calibration Technician. Chad holds a Bachelor of Science in Management from Cornerstone University.